United States debates rising antidepressant prescription rates

Debate is intensifying in the United States regarding the rising rates of antidepressant prescriptions and the long-term implications of Selective Serotonin Reuptake Inhibitor (SSRI) use. Approximately one in six Americans are prescribed antidepressants, with roughly 70 percent of those individuals remaining on the medication for two years or longer.

Discussions led by various media outlets and medical professionals have highlighted concerns regarding withdrawal symptoms, weight gain, sexual dysfunction, and the limited long-term gains observed with SSRIs as a first-line treatment. While some experts argue that the medications are not the problem, others point to the need for better understanding of their exact mechanisms and outcomes.

Adding to the tension, Health and Human Services director Robert F. Kennedy Jr. has called for tighter diagnoses, more stringent prescribing practices, and the wider adoption of safer deprescribing programs to address these trends.